Addus Homecare Co. (NASDAQ:ADUS) has been assigned an average rating of “Buy” from the ten ratings firms that are presently covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating on the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $75.43.
A number of brokerages have recently weighed in on ADUS. Cantor Fitzgerald began coverage on Addus Homecare in a report on Wednesday, September 12th. They issued an “overweight” rating and a $77.00 price objective on the stock. BidaskClub lowered Addus Homecare from a “buy” rating to a “hold” rating in a report on Friday, August 17th. Royal Bank of Canada began coverage on Addus Homecare in a report on Monday, October 8th. They issued an “outperform” rating and a $81.00 price objective on the stock. Zacks Investment Research lowered Addus Homecare from a “hold” rating to a “strong sell” rating in a report on Monday, October 22nd. Finally, Raymond James began coverage on Addus Homecare in a report on Monday, August 20th. They set an “outperform” rating and a $75.00 target price on the stock.
Shares of ADUS stock traded up $1.98 during mid-day trading on Tuesday, reaching $72.28. The stock had a trading volume of 146,139 shares, compared to its average volume of 114,970. The company has a debt-to-equity ratio of 0.37, a quick ratio of 4.19 and a current ratio of 4.19. The firm has a market capitalization of $946.72 million, a PE ratio of 49.85, a P/E/G ratio of 2.86 and a beta of -0.26. Addus Homecare has a 1-year low of $31.20 and a 1-year high of $76.89.
In related news, major shareholder Eos Capital Partners Iii L. P sold 1,024,733 shares of the firm’s stock in a transaction dated Monday, August 20th. The stock was sold at an average price of $59.00, for a total transaction of $60,459,247.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 34.80% of the stock is owned by company insiders.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in ADUS. Smith Asset Management Group LP increased its stake in Addus Homecare by 3.6% during the third quarter. Smith Asset Management Group LP now owns 26,034 shares of the company’s stock worth $1,826,000 after acquiring an additional 900 shares during the last quarter. Rhumbline Advisers grew its stake in shares of Addus Homecare by 14.5% in the second quarter. Rhumbline Advisers now owns 7,630 shares of the company’s stock valued at $437,000 after buying an additional 964 shares in the last quarter. Martingale Asset Management L P grew its stake in shares of Addus Homecare by 3.9% in the third quarter. Martingale Asset Management L P now owns 32,103 shares of the company’s stock valued at $2,253,000 after buying an additional 1,200 shares in the last quarter. Teachers Advisors LLC grew its stake in shares of Addus Homecare by 8.2% in the third quarter. Teachers Advisors LLC now owns 17,138 shares of the company’s stock valued at $1,202,000 after buying an additional 1,306 shares in the last quarter. Finally, American International Group Inc. grew its stake in shares of Addus Homecare by 26.3% in the third quarter. American International Group Inc. now owns 6,277 shares of the company’s stock valued at $440,000 after buying an additional 1,309 shares in the last quarter.
Addus Homecare Company Profile
Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company's personal care services offer assistance with activities of daily living. Its services include assistance with bathing, grooming, oral care, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services, as well as other activities of daily living.
Read More: Marijuana Stocks Future Looks Bright
Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.